“…To evaluate LOH, we used 24 polymorphic microsatellite markers located at the following sites in the 10 genes reported to play a major role in human carcinogenesis: [13][14][15][16][17][18][19][20][21][22] FHIT (3p) (D3S1300, D3S1312, and D3S1313), APC (5q) (D5S346 and D5S82), p16 (9p) (D9S171 and D9S162), TSC-1 (9q) (D9S149, D9S150 and DBH), Int-2 (11q) (INT-2), Rb (13q) (D13S270, D13S273, and D13S176), TSC-2 (16p) (D16S291 and D16S292), p53 (17p) (TP53 and D17S520), Smad 4 (18q) (D18S46, D18S363, and D18S474), and Band M (22q) (D22S1140, D22S1170, and D22S1161). The use of more than one microsatellite marker ensured a higher yield of information for each genomic locus.…”